complex
infecti
agent
initi
autoimmun
respons
mechan
molecular
mimicri
bystand
activ
review
ref
addit
pathogen
might
also
provok
relaps
worsen
preexist
autoimmun
patholog
exampl
common
infect
augment
risk
sever
relaps
multipl
sclerosi
ms
patient
studi
effect
viral
infect
preexist
autoimmun
background
combin
neurotrop
strain
mous
hepat
viru
mhv
mice
express
autoantibodi
cn
antigen
mhv
provok
acut
enceph
follow
proport
surviv
mice
demyelin
diseas
share
sever
featur
ms
litzenburg
colleagu
gener
transgen
mice
refer
antimog
ig
mice
constitut
express
autoantibodi
specif
myelin
oligodendrocyt
glycoprotein
mog
mice
show
exacerb
version
experiment
autoimmun
encephalomyel
eae
develop
spontan
diseas
intracrani
inject
subleth
dose
mhv
result
exacerb
clinic
diseas
mice
mogspecif
antibodi
compar
control
figur
surviv
test
addit
increas
clinic
score
mortal
clinic
sign
also
detect
day
earlier
autoantibodi
transgen
mice
control
dose
pfu
use
data
shown
inject
uvinactiv
viru
pfuequival
trigger
clinic
sign
antimog
ig
mice
suffici
trigger
pathogen
autoantibodi
viral
replic
requir
found
signific
differ
viral
titer
cn
control
mogig
transgen
mice
tabl
show
exacerb
diseas
could
attribut
differ
viral
replic
transfer
singl
dose
serum
antimog
ig
mice
time
infect
suffici
reproduc
clinic
diseas
observ
transgen
anim
figur
result
compar
increas
mortal
surviv
day
recipi
antimog
ig
serum
vs
control
p
result
confirm
antimog
autoantibodi
account
exacerb
virallyinduc
cn
diseas
model
antimog
ig
pfug
indic
break
bloodbrain
barrier
presenc
viral
antigen
tabl
demyelin
score
lesion
brain
antimog
ig
wt
mice
day
postinfect
mhv
model
demyelin
detect
earli
day
postinfect
brain
subset
mice
antimog
antibodi
shown
exacerb
demyelin
eae
ms
examin
luxol
fast
bluestain
brain
section
obtain
antimog
ig
control
mice
preliminari
result
show
signific
differ
number
import
demyelin
lesion
brain
transgen
control
anim
tabl
mechan
respons
augment
virusinduc
patholog
mice
cn
autoantibodi
current
investig
also
tri
determin
abil
trigger
autoaggress
autoantibodi
limit
mhv
gener
featur
viral
infect
cn
studi
illustr
addit
effect
concomit
presenc
autoantibodi
cn
antigen
viral
cn
infect
support
concept
infecti
autoimmun
compon
act
synergi
lead
enhanc
diseas
